Cargando…
Inequality in Drug Utilization among Chronic Myeloid Leukaemia Patients in Malaysia: A Cost-Utility Analysis
BACKGROUND: The burden of chronic myeloid leukaemia (CML) is increasing due to longer patient survival, better life expectancy of the general population, and increasing drug prices. Funding is one of the main concerns in the choice of CML medication used worldwide; thus, patient assistance programme...
Autores principales: | Puteh, Sharifa Ezat Wan, Selamat, Ellyana Mohamad, Aizuddin, Azimatun Noor, Tumian, Nor Rafeah, Sathar, Jameela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971449/ https://www.ncbi.nlm.nih.gov/pubmed/36580008 http://dx.doi.org/10.31557/APJCP.2022.23.12.4253 |
Ejemplares similares
-
Health-related quality of life using EQ-5D among chronic myeloid leukaemia patients in health centres in Klang Valley, Malaysia
por: Wan Puteh, Sharifa Ezat, et al.
Publicado: (2021) -
Specialists’ Dual Practice within Public Hospital Setting: Evidence from Malaysia
por: Fadzil, Malindawati Mohd, et al.
Publicado: (2022) -
Cost volume profit analysis for full paying patient services in Malaysia: A study protocol
por: Mohd Fadzil, Malindawati, et al.
Publicado: (2023) -
Patients’ willingness to pay for their drugs in primary care clinics in an urbanized setting in Malaysia: a guide on drug charges implementation
por: Puteh, Sharifa Ezat Wan, et al.
Publicado: (2017) -
Catastrophic Health Expenditure (CHE) among Cancer Population in a Middle Income Country with Universal Healthcare Financing
por: Puteh, Sharifa Ezat Wan, et al.
Publicado: (2023)